Gapping up
In reaction to strong earnings/guidance: WATT +19.1%, MM +6.9%, URBN +6.8%, XOXO +5.1%, QIHU +4.1%, VSTM +0.9%, RDUS +0.6%
M&A news: BBNK +14.2% (to be acquired by Western Alliance Bancorporation (WAL))
Other news: BONE +11.6% (signed a national distribution agreement with Spartan Medical), DARA +10.5% (announces the acquisition of exclusive North American rights to Oravig from Onxeo S.A.), RESN +9.3% (engaged with a second customer for the design of an RF filter utilizing its Infinite Synthesized Networks, or ISN technology), CS +6.3% (Brady Dougan to leave Credit Suisse as CEO; current Prudential (PUK) CEO Tidjane Thiam to become Chief Executive Officer of CS), MPO +5.2% (executed a Purchase and Sale Agreement with Pintail Oil and Gas for the sale of its Dequincy assets located in Beauregard and Calcasieu Parishes, Louisiana for total consideration of $44 mln), LL +4.2% (announced agenda for its business update conference call to be held on March 12, 2015 at 10am ET), RJET +4.1% (to replace MMS in the S&P SmallCap 600), RMGN +3.4% (cont strength), ORAN +3.1% (still checking), QCOM +2.3% ( announced increases in its capital return program), SWKS +1.9% (to replace PETM in the S&P 500), MRGE +1.7% (Guggenheim Capital disclosed a 10.9% active stake in 13D filing), MMS +1.5% (to replace SWKS in the S&P MidCap 400), NBG +1.5% (still checking), SGYP +1.3% (OrbiMedCapital discloses 13.57% passive stake in 13G filing)
Analyst comments:SVU +2.1% (upgraded to Buy from Hold at Deutsche Bank), RDN +2% (initiated with a Buy at BTIG Research), ARRS +1% (upgraded to Overweight from Equal Weight at Barclays ), GG +0.8% (upgraded to Hold from Underperform at Jefferies), NVDA +0.6% (upgraded to Buy at BofA/Merrill)
In reaction to strong earnings/guidance: WATT +19.1%, MM +6.9%, URBN +6.8%, XOXO +5.1%, QIHU +4.1%, VSTM +0.9%, RDUS +0.6%
M&A news: BBNK +14.2% (to be acquired by Western Alliance Bancorporation (WAL))
Other news: BONE +11.6% (signed a national distribution agreement with Spartan Medical), DARA +10.5% (announces the acquisition of exclusive North American rights to Oravig from Onxeo S.A.), RESN +9.3% (engaged with a second customer for the design of an RF filter utilizing its Infinite Synthesized Networks, or ISN technology), CS +6.3% (Brady Dougan to leave Credit Suisse as CEO; current Prudential (PUK) CEO Tidjane Thiam to become Chief Executive Officer of CS), MPO +5.2% (executed a Purchase and Sale Agreement with Pintail Oil and Gas for the sale of its Dequincy assets located in Beauregard and Calcasieu Parishes, Louisiana for total consideration of $44 mln), LL +4.2% (announced agenda for its business update conference call to be held on March 12, 2015 at 10am ET), RJET +4.1% (to replace MMS in the S&P SmallCap 600), RMGN +3.4% (cont strength), ORAN +3.1% (still checking), QCOM +2.3% ( announced increases in its capital return program), SWKS +1.9% (to replace PETM in the S&P 500), MRGE +1.7% (Guggenheim Capital disclosed a 10.9% active stake in 13D filing), MMS +1.5% (to replace SWKS in the S&P MidCap 400), NBG +1.5% (still checking), SGYP +1.3% (OrbiMedCapital discloses 13.57% passive stake in 13G filing)
Analyst comments:SVU +2.1% (upgraded to Buy from Hold at Deutsche Bank), RDN +2% (initiated with a Buy at BTIG Research), ARRS +1% (upgraded to Overweight from Equal Weight at Barclays ), GG +0.8% (upgraded to Hold from Underperform at Jefferies), NVDA +0.6% (upgraded to Buy at BofA/Merrill)